Report
Our reports provide latest industry trends, forecasts, company profiles, competitive landscape, and strategic insights.
South & Central America Helicobacter Pylori (H. pylori) Non-invasive Testing Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Test Type (Serology, Stool Antigen, and Urea Breath), Test Method (Laboratory Based and Point-of-Care), and End User (Hospitals, Clinics, and Diagnostic Laboratories)
- Report Code : BMIRE00027546
- Pages : 114
The helicobacter pylori (H. pylori) non-invasive testing market in South & Central America is expected to grow from US$ 26.14 million in 2022 to US$ 34.64 million by 2028; it is estimated to grow at a CAGR of 4.8% from 2022 to 2028.
Introduction of Artificial Intelligence to Provide Opportunities to South & Central America Helicobacter
Pylori (H. pylori) Non-invasive Testing Market Players
The advancement in the field of computer technologies has led to the introduction of artificial intelligence technologies, which have been utilized to enhance the diagnosis and predict disease progression and treatment planning. Several studies have shown the capability of artificial intelligence in predicting H. pylori status for diagnosing gastritis. In 2019, Cancer Informatics and Inspirata entered into a technical partnership with DeePathology to grant joint customers the ability to utilize the DeePathology H. pylori decision support system, a screening tool, directly from Dynamyx, a digital pathology solution by Inspirata. The product can enhance reporting accuracy and safely accelerate the H. Pylori diagnostic process. Thus, the emergence of artificial intelligence will offer new opportunities for pharmaceutical companies, which is expected to provide growth opportunities to the helicobacter pylori (H. pylori) non-invasive testing market.
Market Overview
The number of cancer cases in Argentina is increasing at a steady rate. According to WHO, in 2020, ~130,878 new cases of cancer were diagnosed, of which 22,024 were breast cancer, while 15,605 were colorectal cancer and others. Further, ~70,000 deaths are caused by cancer per year, which is the third-highest cancer mortality rate in Latin America. Breast cancer is the most common type, with 73 cases per 100,000 women each year. Moreover, according to OECD, the healthcare expenditure in Argentina has increased. The surge is due to a growing need for health systems, infrastructure, human resources, diagnostics, treatment, and financing owing to the rising number of diseases and infections across the country. These factors are expected to provide significant growth opportunities to the (H. pylori) non-invasive testing market players during the forecast period.
South & Central America Helicobacter Pylori (H. pylori) Non-invasive Testing Market Revenue and Forecast to 2028 (US$ Million)
South & Central America Helicobacter Pylori (H. pylori) Non-invasive Testing Market Segmentation
The South & Central America helicobacter pylori (H. pylori) non-invasive testing market is segmented on test type, test method, end user, and country.
Based on test type, the South & Central America Helicobacter pylori (H. pylori) non-invasive testing market is segmented into serology, stool antigen, and urea breathe. In 2022, the urea breath segment is expected to hold the largest share of the market. Based on test method, the South & Central America Helicobacter pylori (H. pylori) non-invasive testing market is bifurcated into laboratory based and point of care. The laboratory based segment is expected to hold a larger share of the market in 2022. Based on end user, the South & Central America Helicobacter pylori (H. pylori) non-invasive testing market is segmented into hospitals, clinics, and diagnostic laboratories. The diagnostic laboratories segment is expected to hold the largest share of the market in 2022. Based on country, the South & Central America Helicobacter pylori (H. pylori) non-invasive testing market is segmented into Brazil, Argentina, and the Rest of South & Central America. Further, Brazil is expected to hold the largest share of the market in 2022. Abbott Laboratories; Bio-Rad Laboratories Inc.; CerTest Biotec; Coris BioConcept; DiaSorin S.p.A.; Meridian Bioscience Inc.; QuidelOrtho Corporation; Sekisui Diagnostics; Shenzhen Zhonghe Headway Bio-Sci & Tech Co., Ltd; and Thermo Fisher Scientific Inc. are the leading companies operating in the helicobacter pylori (H. pylori) non-invasive testing market in South & Central America.
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 SAM Helicobacter Pylori (H. pylori ) Non-invasive Testing Market – By Test Type
1.3.2 SAM Helicobacter Pylori (H. pylori) Non-invasive Testing Market – By Test Method
1.3.3 SAM Helicobacter Pylori (H. pylori) Non-invasive Testing Market – By End User
1.3.4 SAM Helicobacter Pylori (H. pylori ) Non-invasive Testing Market – By Country
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. SAM Helicobacter Pylori (H. pylori ) Non-invasive Testing Market – Market Landscape
4.1 Overview
4.2 SAM PEST Analysis
4.3 Experts Opinion
5. SAM Helicobacter Pylori (H. pylori ) Non-Invasive Testing Market – Key Industry Dynamics
5.1 Key Market Drivers
5.1.1 Increasing prevalence of H. pylori bacterial infection
5.1.2 New Product Launches & FDA Approvals for Noninvasive Tests
5.1.3 Spreading Awareness Among Individuals Regarding Diagnosis of H. pylori
5.1.4 Rise in Investments by Pharmaceutical Companies
5.2 Key Market Restraints
5.2.1 Low Diagnosis Rate
5.3 Key Market Opportunities
5.3.1 Increasing Number of Conferences and Events for Research
5.3.2 Introduction of Artificial Intelligence
5.4 Future Trends
5.4.1 Increasing Use of Home-Based POC Devices
5.4.2 Diagnosis for Resistance
5.5 Impact Analysis
6. Helicobacter pylori (H. pylori ) Non-Invasive Testing Market– SAM Analysis
6.1 SAM Helicobacter pylori (H. pylori) Non-Invasive Testing Market Revenue Forecast and Analysis
7. SAM Helicobacter pylori (H. pylori ) Non-Invasive Testing Market Analysis– by Test Type
7.1 Overview
7.2 SAM Helicobacter pylori (H. pylori ) Non-invasive Testing Market, By Test Type 2022 & 2028 (%)
7.3 Serology Test
7.3.1 Overview
7.3.2 SAM Serology Test Market Revenue and Forecasts to 2028 (US$ Mn)
7.4 Stool Antigen Test
7.4.1 Overview
7.4.2 SAM Stool Antigen Test Market Revenue and Forecasts to 2028 (US$ Mn)
7.5 Urea Breath Test
7.5.1 Overview
8. SAM Helicobacter pylori (H. pylori ) Non-Invasive Testing Market Analysis– by Test Method
8.1 Overview
8.2 SAM Helicobacter pylori (H. pylori) Non-invasive Testing Market, By Test Method 2022 & 2028 (%)
8.3 Laboratory Based Tests
8.3.1 Overview
8.3.2 SAM Laboratory Based Tests Market Revenue and Forecasts to 2028 (US$ Mn)
8.4 Point Of Care Tests
8.4.1 Overview
8.4.2 SAM Point of Care Tests Market Revenue and Forecasts to 2028 (US$ Mn)
9. SAM Helicobacter pylori (H. pylori ) Non-invasive Testing Market Analysis– by End User
9.1 Overview
9.2 SAM Helicobacter pylori (H. pylori ) Non-invasive Testing Market, By End User 2018 & 2028 (%)
9.3 Hospitals
9.3.1 Overview
9.3.2 SAM Hospitals Market Revenue and Forecasts to 2028 (US$ Mn)
9.4 Clinics
9.4.1 Overview
9.4.2 SAM Clinics Market Revenue and Forecasts to 2028 (US$ Mn)
9.5 Diagnostic Laboratories
9.5.1 Overview
9.5.2 SAM Diagnostic Laboratories Market Revenue and Forecasts to 2028 (US$ Mn)
10. SAM Helicobacter Pylori (H. pylori ) Non-invasive Testing Market Revenue and Forecasts to 2028 – Country Analysis
10.1 Overview
10.1.1 SAM Helicobacter pylori (H. pylori ) Non-invasive Testing Market Revenue and Forecasts to 2028, By Country (%)
10.1.1.1 Argentina Helicobacter pylori (H. pylori ) Non-invasive Testing Market Revenue and Forecasts to 2028 (US$ Mn)
10.1.1.1.1 Argentina Helicobacter pylori (H. pylori ) Non-invasive Testing Market Revenue and Forecasts to 2028 (US$ Mn)
10.1.1.1.2 Argentina Helicobacter pylori (H. pylori ) Non-invasive Testing Market Revenue And Forecasts to 2028, By Test (US$ Mn)
10.1.1.1.3 Argentina Helicobacter pylori (H. pylori ) Non-Invasive Testing Market Revenue And Forecasts To 2028, By Test Method (US$ MN)
10.1.1.1.4 Argentina Helicobacter pylori (H. pylori ) Noninvasive Testing Market Revenue And Forecasts to 2028, By End User (US$ Mn)
10.1.1.2 Brazil Helicobacter pylori (H. pylori ) Non-Invasive Testing Market Revenue and Forecasts to 2028 (US$ Mn)
10.1.1.2.1 Brazil Helicobacter pylori (H. pylori ) Noninvasive Testing Market Revenue and Forecasts to 2028 (US$ Mn)
10.1.1.2.2 Brazil Helicobacter pylori (H. pylori ) Noninvasive Testing Market Revenue and Forecasts to 2028, By Test (US$ Mn)
10.1.1.2.3 Brazil Helicobacter pylori (H. pylori ) Non-Invasive Testing Market Revenue and Forecasts To 2028, By Test Method (US$ MN)
10.1.1.2.4 Brazil Helicobacter pylori (H. pylori ) Noninvasive Testing Market Revenue and Forecasts to 2028, By End User (US$ Mn)
10.1.1.3 Rest of SAM Helicobacter pylori (H. pylori ) Non-invasive Testing Market Revenue and Forecasts to 2028 (US$ Mn)
10.1.1.3.1 Rest of SAM Helicobacter pylori (H. pylori ) Non-invasive Testing Market Revenue and Forecasts to 2028 (US$ Mn)
10.1.1.3.2 Rest of SAM Helicobacter pylori (H. pylori ) Non-invasive Testing Market Revenue And Forecasts to 2028, By Test (US$ Mn)
10.1.1.3.3 Rest of SAM Helicobacter pylori (H. pylori ) Non-Invasive Testing Market Revenue And Forecasts To 2028, By Test Method (US$ MN)
10.1.1.3.4 Rest of SAM Helicobacter pylori (H. pylori ) Non-invasive Testing Market Revenue And Forecasts to 2028, By End User (US$ Mn)
11. Helicobacter Pylori (H. Pylori ) Non-Invasive Testing Market–Industry Landscape
11.1 Overview
11.2 Growth Strategies in the Helicobacter Pylori (H. Pylori ) Non-Invasive Testing Market
11.3 Inorganic Growth Strategies
11.3.1 Overview
11.4 Organic Growth Strategies
11.4.1 Overview
12. Company Profile
12.1 DiaSorin S.p.A.
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Meridian Bioscience, Inc.
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 QuidelOrtho Corporation
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Abbott Laboratories
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Thermo Fisher Scientific Inc.
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 CerTest Biotec
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Sekisui Diagnostics
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Coris BioConcept
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Shenzhen Zhonghe Headway Bio-Sci & Tech Co., Ltd.
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Bio-Rad Laboratories, Inc.
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms
LIST OF TABLES
Table 1. Argentina Helicobacter pylori (H. pylori) Noninvasive Testing Market Revenue And Forecasts to 2028, By Test (US$ Mn)
Table 2. Argentina Helicobacter Pylori (H. Pylori) Non-Invasive Testing Market, by Test Method – Revenue and Forecast to 2028 (USD Million)
Table 3. Argentina Helicobacter Pylori (H. Pylori) Non-Invasive Testing Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 4. Brazil Helicobacter Pylori (H. Pylori) Non-Invasive Testing Market, by Test Type – Revenue and Forecast to 2028 (USD Million)
Table 5. Brazil Helicobacter Pylori (H. Pylori) Non-Invasive Testing Market, by Test Method – Revenue and Forecast to 2028 (USD Million)
Table 6. Brazil Helicobacter Pylori (H. Pylori) Non-Invasive Testing Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 7. Rest of SAM Helicobacter Pylori (H. Pylori) Non-Invasive Testing Market, by Test Type – Revenue and Forecast to 2028 (USD Million)
Table 8. Rest of SAM Helicobacter Pylori (H. Pylori) Non-Invasive Testing Market, by Test Method – Revenue and Forecast to 2028 (USD Million)
Table 9. Rest of SAM Helicobacter Pylori (H. Pylori) Non-Invasive Testing Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 10. Recent Inorganic Growth Strategies in the Helicobacter Pylori (H. Pylori) Non-Invasive Testing Market
Table 11. Recent Organic Growth Strategies in the Helicobacter Pylori (H. Pylori) Non-Invasive Testing Market
Table 12. Glossary of Terms
LIST OF FIGURES
Figure 1. SAM Helicobacter Pylori (H. pylori ) Non-invasive Testing Market Segmentation
Figure 2. SAM Helicobacter Pylori (H. pylori ) Non-invasive Testing Market, By Country
Figure 3. SAM Helicobacter Pylori (H. pylori) Non-invasive Testing Market Overview
Figure 4. Urea Breath Segment Held Largest Share of Test Type Segment in SAM Helicobacter Pylori (H. pylori) Non-invasive Testing Market
Figure 5. Argentina is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. SAM: PEST Analysis
Figure 7. Experts Opinion
Figure 8. SAM Helicobacter pylori Non-Invasive Testing Market Impact Analysis of Driver and Restraints
Figure 9. SAM Helicobacter pylori (H. pylori) Non-Invasive Testing Market– Revenue Forecast and Analysis – 2020 – 2028
Figure 10. SAM Helicobacter pylori (H. pylori) Noninvasive Testing Market, by Test Type 2022 & 2028 (%)
Figure 11. SAM Serology Test Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 12. SAM Stool Antigen Test Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 13. SAM Urea Breath Test Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 14. SAM Helicobacter pylori (H. pylori) Noninvasive Testing Market, by Test Method 2022 & 2028 (%)
Figure 15. SAM Laboratory Based Tests Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 16. SAM Point Of Care Tests Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 17. SAM Helicobacter pylori (H. pylori) Noninvasive Testing Market, by End User 2018 & 2028 (%)
Figure 18. SAM Hospitals Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 19. SAM Clinics Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 20. SAM Diagnostic Laboratories Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 21. SAM Helicobacter Pylori (H. pylori) Noninvasive Testing Market Revenue Overview, by Country, 2022 (US$ Mn)
Figure 22. SAM Helicobacter pylori (H. pylori) Noninvasive Testing Market Revenue and Forecasts to 2028, By Country (%)
Figure 23. Argentina Helicobacter pylori (H. pylori) Noninvasive Testing Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 24. Brazil Helicobacter pylori (H. pylori) Noninvasive Testing Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 25. Rest of SAM Helicobacter pylori (H. pylori) Noninvasive Testing Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 26. Growth Strategies in the Helicobacter Pylori (H. Pylori) Non-Invasive Testing Market
● Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the South & Central America helicobacter pylori (H. pylori) non-invasive testing market
● Highlights key business priorities in order to assist companies to realign their business strategies
● The key findings and recommendations highlight crucial progressive industry trends in the South & Central America helicobacter pylori (H. pylori) non-invasive testing market, thereby allowing players across the value chain to develop effective long-term strategies
● Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
● Scrutinize in-depth South & Central America market trends and outlook coupled with the factors driving the helicobacter pylori (H. pylori) non-invasive testing market, as well as those hindering it
● Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution
The List of Companies – South & Central America Helicobacter Pylori (H. pylori) Non-invasive Testing Market
● Abbott Laboratories
● Bio-Rad Laboratories Inc.
● CerTest Biotec; Coris BioConcept
● Coris BioConcept
● DiaSorin S.p.A.
● Meridian Bioscience Inc.
● QuidelOrtho Corporation
● Sekisui Diagnostics
● Shenzhen Zhonghe Headway Bio-Sci & Tech Co., Ltd
● Thermo Fisher Scientific Inc.
At 4.8% CAGR, the South & Central America Helicobacter Pylori (H. pylori) Non-invasive Testing Market is speculated to be worth US$ 34.64 Million by 2028, says The Insight Partners
According to The Insight Partners’ research, the South & Central America helicobacter pylori (H. pylori) non-invasive testing market was valued at US$ 26.14 million in 2022 and is expected to reach US$ 34.64 million by 2028, registering an annual growth rate of 4.8% from 2022 to 2028. Increasing use of home-based POC devices and new product launches & FDA approvals for noninvasive tests are the critical factors attributed to the market expansion.
The increasing awareness of Helicobacter pylori infections such as peptic ulcers and gastritis is bringing the test diagnostics kits conveniently and quickly to the patient at home. Most clinicians recognize POC testing as a requirement for the early detection of life-threatening situations because laboratory results can be made available in real-time. In low- and middle-income countries, POC diagnostic and monitoring devices are anticipated to become universal in-home setups and at doctor’s offices or hospitals.
In stool antigen testing (STA), there are two types of assays, quantitative enzyme immunoassays (EIA), which are analyzed in a laboratory setting, and qualitative immunochromatography assays (ICA), which are regularly used as a rapid test at home or in the clinic. Therefore, these factors mentioned above have increased the demand for POCs for diagnostic purposes.
On the contrary, very low diagnosis rate hurdles the growth of South & Central America helicobacter pylori (H. pylori) non-invasive testing market.
Based on test type, the South & Central America Helicobacter pylori (H. pylori) non-invasive testing market is segmented into serology, stool antigen, and urea breathe. In 2022, the urea breath segment is expected to hold the largest share of the market in 2022 with a share of 45.1%, amassing US$ 11.78 million. It is projected to garner US$ 15.95 million by 2028 to expand at 5.8% CAGR during 2022–2028. Based on test method, the South & Central America Helicobacter pylori (H. pylori) non-invasive testing market is bifurcated into laboratory based and point of care. The laboratory based segment is expected to hold a larger share of the market in 2022 with a share of 75.4%, amassing US$ 19.72 million. It is projected to garner US$ 26.47 million by 2028 to expand at 5.0% CAGR during 2022–2028. Based on end user, the South & Central America Helicobacter pylori (H. pylori) non-invasive testing market is segmented into hospitals, clinics, and diagnostic laboratories. The diagnostic laboratories segment is expected to hold the largest share of the market in 2022 with a share of 58.8%, amassing US$ 15.37 million. It is projected to garner US$ 20.66 million by 2028 to expand at 5.0% CAGR during 2022–2028. Our regional analysis states that Brazil captured 56.4% market share in 2022. It was assessed at US$ 14.75 million in 2022 and is likely to hit US$ 19.30 million by 2028, exhibiting a CAGR of 4.6% during the forecast period.
Key players dominating the South & Central America helicobacter pylori (H. pylori) non-invasive testing market are Abbott Laboratories; Bio-Rad Laboratories Inc.; CerTest Biotec; Coris BioConcept; DiaSorin S.p.A.; Meridian Bioscience Inc.; QuidelOrtho Corporation; Sekisui Diagnostics; Shenzhen Zhonghe Headway Bio-Sci & Tech Co., Ltd; and Thermo Fisher Scientific Inc.
Below are mentioned a few key market developments by major players:
In Dec 2021, Thermo Fisher Scientific Inc. announced that it has completed its acquisition of PPD, Inc. (Nasdaq: PPD), a leading global provider of clinical research services to the biopharma and biotech industry, for $17.4 billion. In April 2020, Meridian Bioscience, Inc. has completed the acquisition of Exalenz Bioscience Ltd., the Modiin, Israel-based provider of the BreathID Breath Test Systems, a urea breath test platform for the detection of Helicobacter pylori.
Related Reports
- $3,000.00 – $5,000.00
